Skip to main content

Table 1 Schedule of assessments for immediate treatment group

From: NAV-KIDS2 trial: protocol for a multi-centre, staggered randomised controlled trial of a patient navigator intervention in children with chronic kidney disease

 

Screen

Random

Treat (1mo)

Treat (3mo)

End treat (6mo)

Post-treat (6mo)

Post-treat (12mo)

Day

 

0

28

84

168

336

504

Eligibility Criteria

x

      

Demographics

 

x

     

CKD Information

 

x

x

x

x

x

x

Medical History

 

x

x

x

x

x

x

Physical Examination

 

x

x

x

x

x

x

Bloods

 

x

  

x

x

x

Immunosuppressive Medications

 

x

x

x

x

x

x

Concomitant Medications

 

x

x

x

x

x

x

SRH (Child and Caregiver)

 

x

x

x

x

x

x

Educational Background

 

x

     

School Absenteeism

 

x

x

x

x

x

x

HUI Questionnaire

 

x

x

x

x

x

x

Caregiver Satisfaction Questionnaire (Caregiver)

 

x

x

x

x

x

x

Patient Navigator Satisfaction Questionnaire (Caregiver)

  

x

x

x

  

Adverse events

  

x

x

x

x

x

Hospitalisation

  

x

x

x

x

x

Data linkage (NDI, ANZDATA, MBS, PBS)

      

x

Qualitative interviews/questionnaires (subset of participants only)

 

x

 

x

x

x

 
  1. Abbreviations. CKD: Chronic kidney disease, SRH: Self-rated health, HUI: Health utilities index, NDI: National death index, ANZDATA: Australia and New Zealand Dialysis and Transplant Registry, MBS: Medicare Benefits Schedule, PBS: Pharmaceutical Benefits Scheme